Refine your search results with filters

Specialty
Additional Specialty
Gender
Years of Experience
Level of Expertise

Last Updated: 10/19/2022

Looking for the best doctor for you?
Start Here
 
 
 
 
Learn about our expert tiers
Learn more
Learn about our doctor expertise tiers.
If you have a rare or serious condition, you may want to seek advice from the best doctor you can find.
In most cases, seeking advice from top-tier doctors may not be necessary.
Elite
  • Global leaders in their field
  • Publish in medical journals frequently
  • Speak at conferences
  • Participate in clinical trials
  • Likely to work with cutting edge treatments
  • Likely to hold leadership positions in their organization
Distinguished
  • Leaders in their field
  • Strong research portfolio
  • Likely to work with cutting edge treatments
  • Likely to be a leader in their field regionally
Advanced
  • Excellent at diagnosing and treating conditions.
  • Treat many patients and have extensive experience in their field.
  • May not publish, speak at conferences, or participate in clinical trials.
Experienced
  • Primarily treat patients rather than focus on research.
  • May be specialists or primary care physicians.
  • Have great experience in diagnosing and treating conditions.
  • Majority of doctors fall within this rating.
Find a second opinion
Find now
Location:
Enter a Location
Radius:
Global
1,310 doctors found
Sort By
Elite
Elite

Are you looking for a specific type of Non-Small Cell Lung Cancer (NCSLC)?

Common conditions include: EGFR Positive Lung Cancer, Large-Cell Lung Carcinoma, Lung Adenocarcinoma, Squamous Cell Lung Carcinoma

Find a second opinion
Learn about our expert tiers
Elite
Elite
Elite
Elite
Elite
Elite
Elite
Elite
Elite
Elite
Elite
Distinguished
Distinguished
Distinguished
Distinguished
Distinguished
Distinguished
Distinguished
Showing 1-20 of 1,310

Last Updated: 10/19/2022

Non-small cell lung cancer (NSCLC) is the most common type of malignancy (cancer) that affects the lungs, accounting for nearly 85% of lung cancers. While there are several types of non-small cell lung cancer, the three most common types are 1) adenocarcinoma, 2) squamous cell carcinoma, and 3) large cell carcinoma.  Adenocarcinoma occurs in the outer region of the lung and is the most common form of non-small cell lung cancer in the United States. Squamous cell carcinoma occurs in the center of the lung next to the bronchus (airway) and accounts for 25% of non-small cell cancers. Large cell carcinoma occurs in any part of the lung and accounts for 10% of non-small cell lung cancers. In addition to these three common types of non-small cell lung cancer, there are some less common types: pleomorphic (variable in size and shape), carcinoid tumor, salivary gland carcinoma, and unclassified carcinoma. Non-small lung cancer is classified in the following stages: Occult stage – Cancer is undetectable (hidden). Stage 0 – Carcinoma in situ, or the earliest stage at which non-small lung cancer can be detected. Stage I – Cancer is only in the lung with no spread. Stage II – Cancer is in the lung and close lymph nodes. Stage III – Cancer is in the lung and median (middle) chest lymph nodes, which is known as locally advanced lung cancer. This stage has two subtypes: 1) Stage IIIA – Cancer has only spread to same side chest lymph nodes; and 2) Stage IIIB – Cancer has spread to opposite side chest lymph nodes, or above the collarbone. Stage IV – Advanced lung cancer that has spread to both lungs, the fluid surrounding the lungs, or other organs or parts of the body.

Behind the List

MediFind is the industry authority on identifying the leading medical experts and latest research in order to help patients facing complex health challenges, including , make better health decisions. Leveraging our expertise in natural language processing and machine learning across thousands of diseases, we uncover physicians who are leading authorities on . MediFind identifies these experts using proprietary world-class models that assess over 2.5 million global doctors based on a range of variables, including research leadership, patient volume, peer standing, and connectedness to other experts. Learn more about our methodology by exploring how MediFind works.